StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Raised to $357 at RBC Capital
July 25, 2018 7:44 AM
RBC Capital raised its price target on Biogen (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Biogen (BIIB), Eisai Highlight Detailed Results from Phase II Clinical Study of Elenbecestat at AAIC 2018
July 25, 2018 10:38 AM
Biogen (BIIB) PT Raised to $392 at Morgan Stanley
July 25, 2018 7:46 AM
Biogen (BIIB) PT Raised to $348 at Baird
July 25, 2018 6:40 AM
Biogen (BIIB) PT Raised to $320 at Barclays
July 25, 2018 3:35 AM
Biogen (BIIB) PT Raised to $445 at JPMorgan
July 24, 2018 1:55 PM
Biogen (BIIB) Tops Q2 EPS by 56c, FY Guidance Tops Consensus
July 24, 2018 6:37 AM
